Outset Medical, Inc.
OM
$4.62
-$0.07-1.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.50% | -1.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.50% | -1.89% | |||
| Cost of Revenue | -5.26% | -6.71% | |||
| Gross Profit | -1.11% | 5.53% | |||
| SG&A Expenses | -5.68% | 12.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.70% | 2.78% | |||
| Operating Income | 4.03% | -11.48% | |||
| Income Before Tax | 3.27% | -11.25% | |||
| Income Tax Expenses | 128.42% | -76.49% | |||
| Earnings from Continuing Operations | 2.63% | -9.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.63% | -9.27% | |||
| EBIT | 4.03% | -11.48% | |||
| EBITDA | 3.73% | -13.15% | |||
| EPS Basic | 5.59% | -9.06% | |||
| Normalized Basic EPS | 6.20% | -11.05% | |||
| EPS Diluted | 5.59% | -9.06% | |||
| Normalized Diluted EPS | 6.20% | -11.05% | |||
| Average Basic Shares Outstanding | 3.12% | 0.19% | |||
| Average Diluted Shares Outstanding | 3.12% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||